CTRI/2024/04/065339
Not yet recruiting
Phase 3
An Open Label Randomized Controlled Trial to evaluate the effect of Dapagliflozin on Cardiac autonomic functions in T2DM patients - Nill
Krishna Keerthi Annepu0 sites0 target enrollmentTBD
Overview
- Phase
- Phase 3
- Intervention
- Not specified
- Conditions
- Health Condition 1: E119- Type 2 diabetes mellitus without complications
- Sponsor
- Krishna Keerthi Annepu
- Status
- Not yet recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\. Type 2 DM patients
- •2\. Patients who are willing to participate in the study.
Exclusion Criteria
- •1\. Type 1 DM
- •2\. Hypertensives
- •3\. heart failure
- •4\. valvular disease
- •6\. Renal failure
- •Patients on drugs like beta\-receptor blockers, antihypertensives, sedatives
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Phase 2
To study the effect of Bhunimbadi Vati and its add-on effect with Tablet Glimepiride Metformin in Madhumeha wsr to Type 2 Diabetes mellitusHealth Condition 1: E119- Type 2 diabetes mellitus without complicationsCTRI/2023/03/050496Dr Kiran Damoo Ubhe
Recruiting
Phase 2
Management of pelvic organ prolapse through AyurvedaCTRI/2023/09/057495Dr Salini P
Recruiting
Phase 2
Effect of cholestyramine on post-ESD ulcer healingJPRN-jRCTs031200235Tamura Shigeki100
Not yet recruiting
Phase 2
Effect of Shatavari And Dadima In Abnormal Menstrual Bleeding In Adolescent Girls.Health Condition 1: E288- Other ovarian dysfunctionCTRI/2022/03/041315DRASHWINI NARAYAN KARANDIKAR
Not yet recruiting
Not Applicable
A trial to assess the role of serial physical examination for well appearing babies at risk of sepsisCTRI/2024/04/066566ONE